ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
3 announcements with these filters
CRISIL Ratings has continued the ratings on Anupam Rasayan India Ltd's bank facilities and non-convertible debentures, maintaining the 'Rating Watch with Developing Implications'.
India Ratings and Research updated Anupam Rasayan's credit rating to 'IND AA-' with Negative Implications. Ratings cover bank loans and NCDs, reflecting current creditworthiness assessments.
CRISIL assigned 'Crisil A+' to Anupam Rasayan's ₹160 Crore NCDs and placed ₹1,620 Crore bank facilities on rating watch. This follows the acquisition of Bliss GVS Pharma.